Optional callout banner for highlighted news or events

Learn More
Contact Us
Pii Presents Your Next Must-Read:

IND Strategy That Keeps You on Track: Parenteral Drug Development Built for the Fast Lane

Start Smart or Start Over

The path to IND submission for novel injectables is highly time-sensitive. Every delay eats into patent life and burns capital, so the ability to move quickly shapes today’s valuation and tomorrow’s market opportunity.

What’s inside?

  • Common causes of IND delays—and how to prevent unnecessary rework
  • The importance of early coordination across formulation, packaging, and fill-finish
  • How to integrate regulatory and QA considerations into your early development strategy
  • What to look for in a CDMO to support rapid IND and long-term growth
  • How Accelevate™ streamlines early development and accelerates IND readiness

This guide is designed for early development leaders navigating the time-critical path to IND submission—to help you spot what’s coming, shift gears faster, and avoid the detours that risk derailing IND.

Download: IND Strategy That Keeps You on Track: Parenteral Drug Development Built for the Fast Lane

crossmenu